Back to search
Hypersensitivity, Drug
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Hypersensitivity, Drug trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Hypersensitivity, Drug trials you may qualify forThe purpose of this study is to compare the incidence of early postoperative skin complications including allergic contact dermatitis, blistering, and erythema…
This study aims to assess quabodepistat-based treatment regimens for RR/MDR-TB. The study will enroll adults and adolescents with rifampicin-resistant or multid…
HAE is a rare condition. It causes sudden swelling under the skin and inside the body, like in the belly, throat, or genitals. This swelling happens because of…
Pierre Fabre Laboratories have developed a cream with medical device status, RV4421B-EV0407 indicated for the treatment of eczemas, including atopic eczema, con…
People with heart failure who do not take their medications as prescribed are at high risk of complications leading to hospitalization, death and poor quality o…
This is an open-label, two-part Phase 2 study investigating CGT9486 for the treatment of patients with Advanced Systemic Mastocytosis (AdvSM), including patient…
The primary objective is to examine the efficacy of an mHealth adherence intervention (Asthma Ctrl) on adherence to daily inhaled corticosteroids as measured by…
This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patient…
Pregnant or lactating women requiring treatment for drug sensitive-TB will be identified and invited for sampling. If they are pregnant when identified, they wi…